SOSV

Ostoform Limited is a medical device company based in Dublin, Ireland, specializing in products designed to manage skin complications for individuals with ostomies. Founded in 2016 as a spin-out from the University of Limerick, Ostoform has developed patented technologies aimed at enhancing ostomy skin health. Its flagship products include a mouldable seal that fits securely around the stoma, preventing corrosive output from contacting the skin, and FLOWASSIST, which directs stoma output away from the skin to minimize irritation and swelling. By addressing these significant challenges faced by ostomy patients, Ostoform aims to improve comfort and overall quality of life, positioning itself as a potential leader in the global ostomy care market.

XFuel is a company focused on producing sustainable and net-zero advanced fuels for the road, marine, and aviation sectors. Founded in 2010 and headquartered in Dublin, Ireland, with additional operations in Palma de Mallorca, Spain, XFuel has developed innovative technology for the efficient conversion of biomass waste into low-carbon fuels. This process results in a clean, drop-in fuel that can be utilized by distributors and consumers globally, offering a cost-effective alternative to traditional fossil fuels. XFuel's production methods lead to up to 85% fewer greenhouse gas emissions compared to conventional fuel production, with a clear pathway towards achieving carbon-neutral and carbon-negative fuel solutions.

Oxyle AG, established in 2020 and headquartered in Zurich, Switzerland, specializes in wastewater treatment solutions. The company offers services to diverse industries including pharmaceuticals, chemicals, food & beverage, research labs, electronics, hospitals, and wastewater plants. Oxyle's proprietary technology eliminates persistent micropollutants such as pharmaceuticals, pesticides, endocrine disruptors, color pigments, and industrial chemicals from wastewater. This helps clients comply with regulations, reduce CO2 emissions by avoiding wastewater incineration, and protect water bodies from toxic pollutants.

Reach Industries is a software development company established in 2020 and based in Bristol, UK. It specializes in creating advanced robotics software aimed at enhancing productivity and quality in laboratory environments. The company's platform offers solutions for predictive quality and maintenance analytics, asset condition monitoring, and process optimization. By enabling clients to efficiently manage material flow and securely store telematics and sensor data in the cloud, Reach Industries seeks to augment the capabilities of scientists and improve overall lab efficiency.

Samphire Neuroscience, founded in 2021 and based in London, specializes in women's health through innovative neurotechnology solutions. The company develops a headband device that utilizes non-invasive electrical neuromodulation to target specific areas of the brain. This approach aims to alleviate symptoms commonly associated with the menstrual cycle, such as pain, fatigue, and mood fluctuations. By focusing on enhancing women's health and lifestyles, Samphire Neuroscience strives to provide effective relief for those affected by these challenges.

Vitarka Therapeutics is a London-based company that specializes in developing medical technologies and solutions aimed at treating various types of cancer. The company has created a targeted non-viral delivery platform designed for intracellular targets, particularly in oncology, neuroscience, and neurodegeneration. This innovative platform works by activating the immune system and normalizing tumor vasculature, significantly improving outcomes for late-stage cancer patients, including those with lung, colon, and breast cancers. By utilizing re-engineered pore-forming proteins, Vitarka Therapeutics enables cell-specific targeting and endosomal release of therapeutic cargo, providing cancer patients with improved prospects for leading normal lives and maintaining hope for the future.

Machine Medicine Technologies Ltd, established in 2017 and based in London, UK, specializes in developing artificial intelligence-driven solutions for healthcare. The company's core product, KELVIN-PD, employs computer vision and pose estimation to objectively measure and analyze movement disorders, such as tremors and bradykinesia, in Parkinson's disease patients using simple video clips. This platform offers secure data management, accessibility from various devices, and affordability, making it a valuable tool for researchers and clinicians.

DeepSpin GmbH, founded in 2019 and based in Berlin, Germany, specializes in the development of an innovative artificial intelligence-powered magnetic resonance imaging (MRI) system. The company's technology aims to significantly reduce the cost, size, and weight of traditional MRI machines, thereby enhancing accessibility to medical imaging for patients worldwide. By utilizing generative topological design for its hardware and deep learning techniques for image processing, DeepSpin's MRI system seeks to make advanced medical imaging available in a variety of previously underserved healthcare settings. This approach not only aims to improve patient care but also to democratize access to essential medical diagnostics globally.

VALANX Biotech GmbH is an innovative biotechnology company based in Klosterneuburg, Austria, founded in 2017. The company specializes in the development and manufacturing of synthetic programmable amino acids, notably Norl, and the reactive amino acid SnapIt. These products are designed to facilitate the creation of antibody-drug conjugates, which enhance cancer treatment by selectively targeting cancer cells. VALANX Biotech’s platform also supports PEGylation of therapeutic peptides and proteins, as well as the directed and oriented immobilization of biosensors and biocatalysts. Additionally, the company offers bioanalytics and mass spectrometry services on demand, helping to streamline the development of site-specific protein-drug conjugates in a cost-effective manner.

GlowDx, established in 2015 and headquartered in Midleton, Ireland, specializes in developing point-of-care diagnostic solutions. The company aims to decentralize molecular testing, enabling local access to improve clinical outcomes and reduce economic burden for patients, particularly in tropical disease diagnosis. GlowDx achieves this by employing novel molecular technology tailored for efficient, on-site diagnostics.

XFuel is a company focused on producing sustainable and net-zero advanced fuels for the road, marine, and aviation sectors. Founded in 2010 and headquartered in Dublin, Ireland, with additional operations in Palma de Mallorca, Spain, XFuel has developed innovative technology for the efficient conversion of biomass waste into low-carbon fuels. This process results in a clean, drop-in fuel that can be utilized by distributors and consumers globally, offering a cost-effective alternative to traditional fossil fuels. XFuel's production methods lead to up to 85% fewer greenhouse gas emissions compared to conventional fuel production, with a clear pathway towards achieving carbon-neutral and carbon-negative fuel solutions.

Sundew is a biotechnology company founded in 2018 and headquartered in Copenhagen. The company specializes in providing biological services designed to treat aquatic pests and diseases through innovative solutions. Utilizing precision fermentation, Sundew develops environmentally-friendly products aimed at addressing challenges in the aquaculture market, including the management of invasive species and ecological issues such as red tides. By focusing on unmet needs within this sector, Sundew enables its clients to create effective, cost-efficient solutions that are both climate-friendly and sustainable.

CroBio Ltd is an agricultural biotechnology company that focuses on developing innovative solutions to enhance water retention in soil, particularly in the face of global agricultural drought. Founded in 2019 and based in Macclesfield, United Kingdom, the company specializes in genetically engineered root-associated bacteria that create a self-sustaining, biologically active material capable of improving soil health. By harnessing expertise in microbiology and engineering, CroBio aims to provide environmentally sustainable solutions that address the challenges of water scarcity in agriculture.

NuKoKo is a manufacturer that specializes in creating cocoa-free chocolate through innovative bean-to-bar processes. The company utilizes ingredients sourced from the UK and has developed patent-pending technology to produce a new type of chocolate that is healthier and more sustainable than traditional options. NuKoKo's products are characterized by low carbon emissions, low sugar content, and high protein levels, allowing consumers to enjoy chocolate while minimizing environmental impact. The focus on healthier, sustainable alternatives positions NuKoKo as a unique player in the chocolate industry, appealing to environmentally conscious consumers.

Samphire Neuroscience, founded in 2021 and based in London, specializes in women's health through innovative neurotechnology solutions. The company develops a headband device that utilizes non-invasive electrical neuromodulation to target specific areas of the brain. This approach aims to alleviate symptoms commonly associated with the menstrual cycle, such as pain, fatigue, and mood fluctuations. By focusing on enhancing women's health and lifestyles, Samphire Neuroscience strives to provide effective relief for those affected by these challenges.

CargoKite is a Munich-based company founded in 2022 that specializes in micro cargo ships aimed at enhancing maritime logistics. The company has developed sailing cargo vessels that leverage high-altitude winds for propulsion, promoting emission-free shipping solutions. By utilizing this innovative technology, CargoKite enables clients to operate small ships with greater efficiency while significantly reducing personnel costs through digitization. The vessels are designed for optimal trackability and autonomous operation, eliminating the need for large energy storage systems and contributing to the decarbonization of the shipping industry.

VALANX Biotech GmbH is an innovative biotechnology company based in Klosterneuburg, Austria, founded in 2017. The company specializes in the development and manufacturing of synthetic programmable amino acids, notably Norl, and the reactive amino acid SnapIt. These products are designed to facilitate the creation of antibody-drug conjugates, which enhance cancer treatment by selectively targeting cancer cells. VALANX Biotech’s platform also supports PEGylation of therapeutic peptides and proteins, as well as the directed and oriented immobilization of biosensors and biocatalysts. Additionally, the company offers bioanalytics and mass spectrometry services on demand, helping to streamline the development of site-specific protein-drug conjugates in a cost-effective manner.

NuKoKo is a manufacturer that specializes in creating cocoa-free chocolate through innovative bean-to-bar processes. The company utilizes ingredients sourced from the UK and has developed patent-pending technology to produce a new type of chocolate that is healthier and more sustainable than traditional options. NuKoKo's products are characterized by low carbon emissions, low sugar content, and high protein levels, allowing consumers to enjoy chocolate while minimizing environmental impact. The focus on healthier, sustainable alternatives positions NuKoKo as a unique player in the chocolate industry, appealing to environmentally conscious consumers.

CroBio Ltd is an agricultural biotechnology company that focuses on developing innovative solutions to enhance water retention in soil, particularly in the face of global agricultural drought. Founded in 2019 and based in Macclesfield, United Kingdom, the company specializes in genetically engineered root-associated bacteria that create a self-sustaining, biologically active material capable of improving soil health. By harnessing expertise in microbiology and engineering, CroBio aims to provide environmentally sustainable solutions that address the challenges of water scarcity in agriculture.

Hexafly is a biotech company based in Kells, Ireland, established in 2016. It specializes in the sustainable farming of insects, particularly the Black Soldier Fly larvae, to produce various products for the aquaculture, animal feed, and plant nutrition sectors. The company focuses on converting food waste into protein meals, oils, and fertilizers, promoting a circular economy. Its product range includes insect oil for fish feed, protein additives for aquaculture, Frass for plant nutrition, and Chitin, a versatile bio-polymer utilized in medicine, cosmetics, and food. Hexafly sells its products online, aiming to provide environmentally friendly solutions in agriculture and contribute to a sustainable food system.

Reach Industries is a software development company established in 2020 and based in Bristol, UK. It specializes in creating advanced robotics software aimed at enhancing productivity and quality in laboratory environments. The company's platform offers solutions for predictive quality and maintenance analytics, asset condition monitoring, and process optimization. By enabling clients to efficiently manage material flow and securely store telematics and sensor data in the cloud, Reach Industries seeks to augment the capabilities of scientists and improve overall lab efficiency.

VALANX Biotech GmbH is an innovative biotechnology company based in Klosterneuburg, Austria, founded in 2017. The company specializes in the development and manufacturing of synthetic programmable amino acids, notably Norl, and the reactive amino acid SnapIt. These products are designed to facilitate the creation of antibody-drug conjugates, which enhance cancer treatment by selectively targeting cancer cells. VALANX Biotech’s platform also supports PEGylation of therapeutic peptides and proteins, as well as the directed and oriented immobilization of biosensors and biocatalysts. Additionally, the company offers bioanalytics and mass spectrometry services on demand, helping to streamline the development of site-specific protein-drug conjugates in a cost-effective manner.

Samphire Neuroscience, founded in 2021 and based in London, specializes in women's health through innovative neurotechnology solutions. The company develops a headband device that utilizes non-invasive electrical neuromodulation to target specific areas of the brain. This approach aims to alleviate symptoms commonly associated with the menstrual cycle, such as pain, fatigue, and mood fluctuations. By focusing on enhancing women's health and lifestyles, Samphire Neuroscience strives to provide effective relief for those affected by these challenges.

Pear Bio is a biotechnology company based in Boston and London that specializes in AI-enabled precision medicine for the treatment of challenging cancers. The company utilizes tumor biopsies and blood samples from cancer patients to identify new therapeutic targets through multi-omics analysis. Pear Bio's proprietary immune-microtumor platform allows for the testing of drug candidates directly on patient tumor samples, enhancing the efficacy of treatments. Additionally, the company employs a unique hydrogel technology that cultivates tumors outside the body, enabling the measurement of drug resistance and streamlining the treatment process. By focusing on tailored drug discovery and smarter combination therapies, Pear Bio aims to improve patient outcomes in cancer care.

NuKoKo is a manufacturer that specializes in creating cocoa-free chocolate through innovative bean-to-bar processes. The company utilizes ingredients sourced from the UK and has developed patent-pending technology to produce a new type of chocolate that is healthier and more sustainable than traditional options. NuKoKo's products are characterized by low carbon emissions, low sugar content, and high protein levels, allowing consumers to enjoy chocolate while minimizing environmental impact. The focus on healthier, sustainable alternatives positions NuKoKo as a unique player in the chocolate industry, appealing to environmentally conscious consumers.

Sundew is a biotechnology company founded in 2018 and headquartered in Copenhagen. The company specializes in providing biological services designed to treat aquatic pests and diseases through innovative solutions. Utilizing precision fermentation, Sundew develops environmentally-friendly products aimed at addressing challenges in the aquaculture market, including the management of invasive species and ecological issues such as red tides. By focusing on unmet needs within this sector, Sundew enables its clients to create effective, cost-efficient solutions that are both climate-friendly and sustainable.

Vitarka Therapeutics is a London-based company that specializes in developing medical technologies and solutions aimed at treating various types of cancer. The company has created a targeted non-viral delivery platform designed for intracellular targets, particularly in oncology, neuroscience, and neurodegeneration. This innovative platform works by activating the immune system and normalizing tumor vasculature, significantly improving outcomes for late-stage cancer patients, including those with lung, colon, and breast cancers. By utilizing re-engineered pore-forming proteins, Vitarka Therapeutics enables cell-specific targeting and endosomal release of therapeutic cargo, providing cancer patients with improved prospects for leading normal lives and maintaining hope for the future.

PILI Inc. is a biotechnology company based in Paris, France, that specializes in the research and manufacturing of bio-fabricated colors using microorganisms. Founded in 2012, the company focuses on developing enzymes and fermentation biotechnologies that transform sugar into renewable and durable dyes and pigments. By offering a sustainable alternative to traditional toxic and non-recyclable inks, PILI aims to replace petrochemical and vegetable-based colorants with organic dyes produced at an industrial scale. The company's innovative approach not only promotes sustainable development but also enables businesses to reduce costs while utilizing environmentally friendly materials.

Pear Bio is a biotechnology company based in Boston and London that specializes in AI-enabled precision medicine for the treatment of challenging cancers. The company utilizes tumor biopsies and blood samples from cancer patients to identify new therapeutic targets through multi-omics analysis. Pear Bio's proprietary immune-microtumor platform allows for the testing of drug candidates directly on patient tumor samples, enhancing the efficacy of treatments. Additionally, the company employs a unique hydrogel technology that cultivates tumors outside the body, enabling the measurement of drug resistance and streamlining the treatment process. By focusing on tailored drug discovery and smarter combination therapies, Pear Bio aims to improve patient outcomes in cancer care.

CroBio Ltd is an agricultural biotechnology company that focuses on developing innovative solutions to enhance water retention in soil, particularly in the face of global agricultural drought. Founded in 2019 and based in Macclesfield, United Kingdom, the company specializes in genetically engineered root-associated bacteria that create a self-sustaining, biologically active material capable of improving soil health. By harnessing expertise in microbiology and engineering, CroBio aims to provide environmentally sustainable solutions that address the challenges of water scarcity in agriculture.

Moirai Biodesign is a biotechnology company focused on developing RNA-based therapies and diagnostics for cancer. Founded in 2016, the company operates from Barcelona, Spain, and specializes in creating non-invasive tests for in-situ diagnosis of various cancers using patient blood samples. Additionally, it provides in-vivo diagnosis systems that assist in surgeries and facilitate patient monitoring. Moirai Biodesign's portfolio includes the discovery of RNA biomarkers, the design of plug-and-play bio devices, and a platform for delivering therapeutic drugs aimed at treating cancer. By advancing these technologies, the company aims to enhance early cancer detection and improve treatment outcomes.

Japet Medical Devices is a French biomedical company focused on developing advanced robotic equipment aimed at enhancing the quality of healthcare. The company specializes in wearable robotic exoskeletons that integrate medical and robotic technologies to improve motion and restore balance, thereby facilitating free movement and reducing pain. Their innovative solutions are designed to assist individuals in overcoming mobility challenges, whether related to occupational tasks or daily activities. By prioritizing efficiency and user-friendliness, Japet Medical Devices aims to transform the quality of life for many people through its cutting-edge technologies.

Multus is a London-based company established in 2019 that specializes in providing tailored growth media solutions for the cultivated meat industry. By utilizing a machine learning-based approach, Multus develops completely animal-free growth media designed specifically for the efficient growth of animal cells. This innovative technology enables cultivated meat companies to scale their production affordably and sustainably, allowing them to focus on creating delicious and environmentally friendly meat alternatives. Additionally, Multus optimizes a variety of growth factor proteins produced by genetically engineered microorganisms, thereby eliminating the reliance on traditional animal serum-based media. Through its efforts, Multus aims to address the diverse needs of various animal cell types and tissues, facilitating the growth of the cultivated meat sector while significantly reducing the environmental and economic impacts associated with conventional meat production.

QV Bioelectronics is focused on improving the lives of brain tumor patients through its innovative electric field therapy implant, GRACE. Developed in collaboration with leading neurosurgeons in the UK, GRACE aims to enhance life expectancy for patients suffering from glioblastoma, a brain tumor known for its poor prognosis and limited treatment options. Recognizing the significant gaps in effective therapies, co-founder Dr. Richard Fu, an academic neurosurgeon, teamed up with biomedical engineer Dr. Chris Bullock to address design flaws in existing electric field therapies. Their solution leverages advanced materials science, including the use of graphene, to optimize device performance and patient outcomes. Since its inception, QV Bioelectronics has garnered nearly $1 million in funding from various UK institutions and over $1 million from international life science investors. The company operates from its research hub in Alderley Park, Cheshire, and boasts a multidisciplinary team with extensive experience in bringing innovative medical devices to the clinic.

NuKoKo is a manufacturer that specializes in creating cocoa-free chocolate through innovative bean-to-bar processes. The company utilizes ingredients sourced from the UK and has developed patent-pending technology to produce a new type of chocolate that is healthier and more sustainable than traditional options. NuKoKo's products are characterized by low carbon emissions, low sugar content, and high protein levels, allowing consumers to enjoy chocolate while minimizing environmental impact. The focus on healthier, sustainable alternatives positions NuKoKo as a unique player in the chocolate industry, appealing to environmentally conscious consumers.

Metabolomic Diagnostics Ltd., established in 2011 and based in Little Island, Ireland, is a medical diagnostics company focused on early disease detection. It specializes in developing a mass spectrometry-based diagnostic platform that analyzes multiple biomarkers simultaneously, enabling predictive diagnosis of complex diseases. The company's primary application is a blood test for predicting the risk of pre-eclampsia, a pregnancy complication characterized by high blood pressure and protein in the urine, which can lead to restricted blood supply to the fetus. By identifying diagnostic biomarker panels and translating them into clinical assays, Metabolomic Diagnostics aims to improve pregnancy outcomes through early intervention.

Oxyle AG, established in 2020 and headquartered in Zurich, Switzerland, specializes in wastewater treatment solutions. The company offers services to diverse industries including pharmaceuticals, chemicals, food & beverage, research labs, electronics, hospitals, and wastewater plants. Oxyle's proprietary technology eliminates persistent micropollutants such as pharmaceuticals, pesticides, endocrine disruptors, color pigments, and industrial chemicals from wastewater. This helps clients comply with regulations, reduce CO2 emissions by avoiding wastewater incineration, and protect water bodies from toxic pollutants.

Vitarka Therapeutics is a London-based company that specializes in developing medical technologies and solutions aimed at treating various types of cancer. The company has created a targeted non-viral delivery platform designed for intracellular targets, particularly in oncology, neuroscience, and neurodegeneration. This innovative platform works by activating the immune system and normalizing tumor vasculature, significantly improving outcomes for late-stage cancer patients, including those with lung, colon, and breast cancers. By utilizing re-engineered pore-forming proteins, Vitarka Therapeutics enables cell-specific targeting and endosomal release of therapeutic cargo, providing cancer patients with improved prospects for leading normal lives and maintaining hope for the future.

Hexafly is a biotech company based in Kells, Ireland, established in 2016. It specializes in the sustainable farming of insects, particularly the Black Soldier Fly larvae, to produce various products for the aquaculture, animal feed, and plant nutrition sectors. The company focuses on converting food waste into protein meals, oils, and fertilizers, promoting a circular economy. Its product range includes insect oil for fish feed, protein additives for aquaculture, Frass for plant nutrition, and Chitin, a versatile bio-polymer utilized in medicine, cosmetics, and food. Hexafly sells its products online, aiming to provide environmentally friendly solutions in agriculture and contribute to a sustainable food system.

Samphire Neuroscience, founded in 2021 and based in London, specializes in women's health through innovative neurotechnology solutions. The company develops a headband device that utilizes non-invasive electrical neuromodulation to target specific areas of the brain. This approach aims to alleviate symptoms commonly associated with the menstrual cycle, such as pain, fatigue, and mood fluctuations. By focusing on enhancing women's health and lifestyles, Samphire Neuroscience strives to provide effective relief for those affected by these challenges.

Machine Medicine Technologies Ltd, established in 2017 and based in London, UK, specializes in developing artificial intelligence-driven solutions for healthcare. The company's core product, KELVIN-PD, employs computer vision and pose estimation to objectively measure and analyze movement disorders, such as tremors and bradykinesia, in Parkinson's disease patients using simple video clips. This platform offers secure data management, accessibility from various devices, and affordability, making it a valuable tool for researchers and clinicians.

Reach Industries is a software development company established in 2020 and based in Bristol, UK. It specializes in creating advanced robotics software aimed at enhancing productivity and quality in laboratory environments. The company's platform offers solutions for predictive quality and maintenance analytics, asset condition monitoring, and process optimization. By enabling clients to efficiently manage material flow and securely store telematics and sensor data in the cloud, Reach Industries seeks to augment the capabilities of scientists and improve overall lab efficiency.

Chronos DX is a biotechnology research company based in London, Germany, specializing in drug development and in vitro diagnostics within the healthcare sector. The company is known for its innovative bioassay technology, which is designed for diagnostics, drug screening, and development. Chronos DX focuses on creating high-performance, low-cost, and scalable technology capable of detecting a variety of biomarkers, including cell-free DNA, micro proteins, exosomes, and metabolites. This technology provides medical professionals with a platform for in-line and in vivo monitoring of biomarkers, enhancing the capabilities of diagnostics and drug development in medical practice.

GlowDx, established in 2015 and headquartered in Midleton, Ireland, specializes in developing point-of-care diagnostic solutions. The company aims to decentralize molecular testing, enabling local access to improve clinical outcomes and reduce economic burden for patients, particularly in tropical disease diagnosis. GlowDx achieves this by employing novel molecular technology tailored for efficient, on-site diagnostics.

Moirai Biodesign is a biotechnology company focused on developing RNA-based therapies and diagnostics for cancer. Founded in 2016, the company operates from Barcelona, Spain, and specializes in creating non-invasive tests for in-situ diagnosis of various cancers using patient blood samples. Additionally, it provides in-vivo diagnosis systems that assist in surgeries and facilitate patient monitoring. Moirai Biodesign's portfolio includes the discovery of RNA biomarkers, the design of plug-and-play bio devices, and a platform for delivering therapeutic drugs aimed at treating cancer. By advancing these technologies, the company aims to enhance early cancer detection and improve treatment outcomes.

XFuel is a company focused on producing sustainable and net-zero advanced fuels for the road, marine, and aviation sectors. Founded in 2010 and headquartered in Dublin, Ireland, with additional operations in Palma de Mallorca, Spain, XFuel has developed innovative technology for the efficient conversion of biomass waste into low-carbon fuels. This process results in a clean, drop-in fuel that can be utilized by distributors and consumers globally, offering a cost-effective alternative to traditional fossil fuels. XFuel's production methods lead to up to 85% fewer greenhouse gas emissions compared to conventional fuel production, with a clear pathway towards achieving carbon-neutral and carbon-negative fuel solutions.

CargoKite is a Munich-based company founded in 2022 that specializes in micro cargo ships aimed at enhancing maritime logistics. The company has developed sailing cargo vessels that leverage high-altitude winds for propulsion, promoting emission-free shipping solutions. By utilizing this innovative technology, CargoKite enables clients to operate small ships with greater efficiency while significantly reducing personnel costs through digitization. The vessels are designed for optimal trackability and autonomous operation, eliminating the need for large energy storage systems and contributing to the decarbonization of the shipping industry.

SensiPass Ltd. specializes in developing advanced 3-factor authentication solutions aimed at enhancing digital security. Founded in 2013 and headquartered in Dublin, Ireland, the company employs a patented interactive platform that utilizes personal human interaction, registered biometric data, and unique virtual objects to create sophisticated digital signatures. This innovative approach replaces traditional passwords and PINs, significantly mitigating risks associated with identity theft and insider threats, particularly in critical sectors such as energy, transportation, communications, government, and defense. SensiPass’s products, including SensiAR and ImmersiveID, enable rapid authentication in various environments, including augmented and virtual reality. The company has received multiple accolades for its contributions to cybersecurity innovation, underscoring its commitment to providing robust identity assurance for users accessing both digital and physical assets.

Moona is an innovative company that specializes in enhancing sleep quality through temperature regulation. Founded in 2016 and based in Paris, France, Moona has developed a sophisticated sleep device that adapts to the user’s head temperature throughout the night, optimizing comfort for better rest. The system utilizes a unique water-based cooling pillow pad made from a thin membrane and memory foam, which facilitates a smooth transition between cooling and heating. This design helps users achieve the ideal body temperature conducive to sleep, ultimately improving overall sleep experiences.

QV Bioelectronics is focused on improving the lives of brain tumor patients through its innovative electric field therapy implant, GRACE. Developed in collaboration with leading neurosurgeons in the UK, GRACE aims to enhance life expectancy for patients suffering from glioblastoma, a brain tumor known for its poor prognosis and limited treatment options. Recognizing the significant gaps in effective therapies, co-founder Dr. Richard Fu, an academic neurosurgeon, teamed up with biomedical engineer Dr. Chris Bullock to address design flaws in existing electric field therapies. Their solution leverages advanced materials science, including the use of graphene, to optimize device performance and patient outcomes. Since its inception, QV Bioelectronics has garnered nearly $1 million in funding from various UK institutions and over $1 million from international life science investors. The company operates from its research hub in Alderley Park, Cheshire, and boasts a multidisciplinary team with extensive experience in bringing innovative medical devices to the clinic.

IPOR Labs is a company based in Zug, Switzerland, that focuses on the development of blockchain-based derivatives software aimed at fixing interest rates. The firm's primary offering, the IPOR Protocol, comprises three components: the IPOR Index, Interest Rate Derivatives, and a Liquidity Pool with an Automated Market Maker (AMM). This software allows users to engage in interest rate swaps, providing a contract counterparty through the liquidity pool. Participants can choose between fixed or floating rates based on the prevailing IPOR rate, thereby gaining transparent oversight and control over their borrowing costs in the decentralized finance (DeFi) market.

Metabolomic Diagnostics Ltd., established in 2011 and based in Little Island, Ireland, is a medical diagnostics company focused on early disease detection. It specializes in developing a mass spectrometry-based diagnostic platform that analyzes multiple biomarkers simultaneously, enabling predictive diagnosis of complex diseases. The company's primary application is a blood test for predicting the risk of pre-eclampsia, a pregnancy complication characterized by high blood pressure and protein in the urine, which can lead to restricted blood supply to the fetus. By identifying diagnostic biomarker panels and translating them into clinical assays, Metabolomic Diagnostics aims to improve pregnancy outcomes through early intervention.

SunGreenH2 is a company focused on producing high-performance electrolysers for green hydrogen generation using advanced materials and nanotechnology. Founded in 2020 and headquartered in Singapore, with additional offices in Melbourne and London, the company has developed a modular and scalable electrolyser stack that enables on-site hydrogen production at a low cost. By utilizing sunlight and water, SunGreenH2's patented technology facilitates the production of zero-emissions hydrogen, supporting sustainable practices across various industries, including transport, buildings, and specialty chemicals. With over a decade of research in electrochemistry and nanotechnology, SunGreenH2 aims to enable widespread adoption of green hydrogen, contributing to a more sustainable energy landscape.

AromatEco assists household brands in becoming more environmentally friendly by delivering renewable flavors and perfumes. Headquartered in London, UK.

LOOX is a London-based mobile application that facilitates on-demand appointment bookings with beauty, health, and fitness professionals. Launched in 2014, the platform connects users with local service providers, streamlining the booking process and enhancing convenience.

Sundew is a biotechnology company founded in 2018 and headquartered in Copenhagen. The company specializes in providing biological services designed to treat aquatic pests and diseases through innovative solutions. Utilizing precision fermentation, Sundew develops environmentally-friendly products aimed at addressing challenges in the aquaculture market, including the management of invasive species and ecological issues such as red tides. By focusing on unmet needs within this sector, Sundew enables its clients to create effective, cost-efficient solutions that are both climate-friendly and sustainable.

Hexafly is a biotech company based in Kells, Ireland, established in 2016. It specializes in the sustainable farming of insects, particularly the Black Soldier Fly larvae, to produce various products for the aquaculture, animal feed, and plant nutrition sectors. The company focuses on converting food waste into protein meals, oils, and fertilizers, promoting a circular economy. Its product range includes insect oil for fish feed, protein additives for aquaculture, Frass for plant nutrition, and Chitin, a versatile bio-polymer utilized in medicine, cosmetics, and food. Hexafly sells its products online, aiming to provide environmentally friendly solutions in agriculture and contribute to a sustainable food system.

ROVENSO is a Swiss company founded in 2016 and headquartered in Villaz-Saint-Pierre, Switzerland, with additional facilities in Shenzhen, China. The company specializes in the development and manufacturing of remotely operated robots designed for challenging environments, focusing on security monitoring, safety assessment, and anomaly detection. Its flagship product, ROVéo, is a four-wheeled rover capable of operating autonomously around the clock in industrial settings, providing cost-effective security solutions that are two to three times more efficient than traditional manned guarding. ROVéo is equipped to patrol both indoor and outdoor spaces, detecting intrusions, thefts, and potential safety hazards such as fires or gas leaks, which can be critical for protecting lives and property. ROVENSO's innovations also include a lightweight immersive control station, LISéo, which enhances the operational capabilities of its robotic systems.

VALANX Biotech GmbH is an innovative biotechnology company based in Klosterneuburg, Austria, founded in 2017. The company specializes in the development and manufacturing of synthetic programmable amino acids, notably Norl, and the reactive amino acid SnapIt. These products are designed to facilitate the creation of antibody-drug conjugates, which enhance cancer treatment by selectively targeting cancer cells. VALANX Biotech’s platform also supports PEGylation of therapeutic peptides and proteins, as well as the directed and oriented immobilization of biosensors and biocatalysts. Additionally, the company offers bioanalytics and mass spectrometry services on demand, helping to streamline the development of site-specific protein-drug conjugates in a cost-effective manner.

Quidli is a Paris-based company founded in 2018 that develops technological infrastructure to facilitate the exchange of equity for labor. Its platform enables businesses to distribute ownership equity as compensation, connecting companies, workers, freelancers, and investors. By leveraging blockchain technology, Quidli allows companies to split equity and incentivize contributions from individuals, thereby enhancing employee engagement and productivity. The platform also offers job security for workers, enabling them to pursue projects aligned with their interests while providing companies with a tool for recruitment. Overall, Quidli aims to create a more connected and equitable labor market.

Samphire Neuroscience, founded in 2021 and based in London, specializes in women's health through innovative neurotechnology solutions. The company develops a headband device that utilizes non-invasive electrical neuromodulation to target specific areas of the brain. This approach aims to alleviate symptoms commonly associated with the menstrual cycle, such as pain, fatigue, and mood fluctuations. By focusing on enhancing women's health and lifestyles, Samphire Neuroscience strives to provide effective relief for those affected by these challenges.

Reach Industries is a software development company established in 2020 and based in Bristol, UK. It specializes in creating advanced robotics software aimed at enhancing productivity and quality in laboratory environments. The company's platform offers solutions for predictive quality and maintenance analytics, asset condition monitoring, and process optimization. By enabling clients to efficiently manage material flow and securely store telematics and sensor data in the cloud, Reach Industries seeks to augment the capabilities of scientists and improve overall lab efficiency.

LOOX is a London-based mobile application that facilitates on-demand appointment bookings with beauty, health, and fitness professionals. Launched in 2014, the platform connects users with local service providers, streamlining the booking process and enhancing convenience.

Criam is a biotechnology company based in Braga, Portugal, founded in 2015. It specializes in the research and development of a medical device that facilitates blood type analysis and the detection of various infectious diseases, including HIV, Brucella, tick fever, syphilis, mononucleosis, and meningitis. The company's portable platform operates independently of electricity and does not require additional laboratory infrastructure, making it accessible for use in diverse settings. Criam's device allows for rapid and accurate blood testing, which enhances clinical decision-making by providing timely health information. The technology is designed to be scalable, with one reader capable of performing multiple tests using specialized cartridges and computer vision algorithms. This innovation aims to improve the efficiency and reliability of blood testing services, ultimately enhancing patient care.

Synthace Limited is a London-based company specializing in the development and operation of software solutions for various industries, including health, pharmaceuticals, food, energy, agri-science, industrial biotechnology, and manufacturing. The company offers Antha, a cloud-based platform designed to automate and enhance biological processes. This platform allows life science researchers to digitize experiments from start to finish, enabling them to design, simulate, and execute reproducible experiments with minimal training. Antha facilitates the integration of experimental data and metadata in a streamlined manner, making it easier for scientists to manage their workflows and increasing the scientific value of their research. Synthace's technology empowers researchers to conduct complex experiments without the need for coding, thereby expanding the possibilities of laboratory experimentation. Founded in 2011, Synthace also has a presence in Cambridge, Massachusetts, and maintains a strategic partnership with Microsoft.

Ostoform Limited is a medical device company based in Dublin, Ireland, specializing in products designed to manage skin complications for individuals with ostomies. Founded in 2016 as a spin-out from the University of Limerick, Ostoform has developed patented technologies aimed at enhancing ostomy skin health. Its flagship products include a mouldable seal that fits securely around the stoma, preventing corrosive output from contacting the skin, and FLOWASSIST, which directs stoma output away from the skin to minimize irritation and swelling. By addressing these significant challenges faced by ostomy patients, Ostoform aims to improve comfort and overall quality of life, positioning itself as a potential leader in the global ostomy care market.

Intelligent Implants is a bioelectronics company based in Cork, Ireland, founded in 2014 by Erik Zellmer, Rory Murphy, Martin Larsson, and John Zellmer. The company specializes in wireless implantable electronics designed to stimulate, steer, and monitor bone growth. Its innovative electrotherapeutic devices provide solutions to treat diseases and facilitate the recovery of bone and other tissues. By integrating data, engineering, and medical expertise, Intelligent Implants develops active and connected medical devices that enhance patient treatment and support healthcare professionals in decision-making. The company's technology allows for the acceleration and adjustment of bone growth, enabling healthcare providers to utilize electro-therapeutics to manage patient conditions effectively.

Kyomei is a company based in Oxford, England, focused on developing a plant-based production system aimed at creating animal proteins for the alternative meat industry. Founded in 2021, Kyomei employs innovative techniques in plant cell biology to scale the production of myoglobin, which enhances the flavor profile of meat alternatives by providing umami. This approach not only aims to improve the taste of plant-based products but also seeks to reduce reliance on carbon-intensive animal agriculture, promoting a more sustainable food system for consumers.

Pear Bio is a biotechnology company based in Boston and London that specializes in AI-enabled precision medicine for the treatment of challenging cancers. The company utilizes tumor biopsies and blood samples from cancer patients to identify new therapeutic targets through multi-omics analysis. Pear Bio's proprietary immune-microtumor platform allows for the testing of drug candidates directly on patient tumor samples, enhancing the efficacy of treatments. Additionally, the company employs a unique hydrogel technology that cultivates tumors outside the body, enabling the measurement of drug resistance and streamlining the treatment process. By focusing on tailored drug discovery and smarter combination therapies, Pear Bio aims to improve patient outcomes in cancer care.

Kutanios is a London-based biotechnology company specialising in the development of biodegradable molecules for skincare products. Their focus lies in creating innovative compounds for anti-ageing, sun protection, and over-the-counter anti-acne treatments. The company's unique selling proposition is its science-based approach, utilising green technology to manufacture molecules with a novel mechanism of action that sequesters lipid peroxides caused by sunlight, atmospheric pollution, and tobacco smoke. This enables their products to effectively prevent ageing, sunburn, and skin cancers.

Kutanios is a London-based biotechnology company specialising in the development of biodegradable molecules for skincare products. Their focus lies in creating innovative compounds for anti-ageing, sun protection, and over-the-counter anti-acne treatments. The company's unique selling proposition is its science-based approach, utilising green technology to manufacture molecules with a novel mechanism of action that sequesters lipid peroxides caused by sunlight, atmospheric pollution, and tobacco smoke. This enables their products to effectively prevent ageing, sunburn, and skin cancers.

IPOR Labs is a company based in Zug, Switzerland, that focuses on the development of blockchain-based derivatives software aimed at fixing interest rates. The firm's primary offering, the IPOR Protocol, comprises three components: the IPOR Index, Interest Rate Derivatives, and a Liquidity Pool with an Automated Market Maker (AMM). This software allows users to engage in interest rate swaps, providing a contract counterparty through the liquidity pool. Participants can choose between fixed or floating rates based on the prevailing IPOR rate, thereby gaining transparent oversight and control over their borrowing costs in the decentralized finance (DeFi) market.

VoltStorage GmbH is a German company specializing in the development and production of solar energy storage systems. Based in Olching, Germany, it utilizes eco-friendly vanadium redox flow technology to create power storage devices that allow homeowners to store surplus solar energy generated during the day for use at night. This innovative approach aims to provide renewable energy availability around the clock, contributing to a cleaner and fairer world for future generations. VoltStorage also offers installation and technical support services for its products, which are sold online. The company's commitment to sustainability underscores its mission to enhance the accessibility of renewable energy.

Multus is a London-based company established in 2019 that specializes in providing tailored growth media solutions for the cultivated meat industry. By utilizing a machine learning-based approach, Multus develops completely animal-free growth media designed specifically for the efficient growth of animal cells. This innovative technology enables cultivated meat companies to scale their production affordably and sustainably, allowing them to focus on creating delicious and environmentally friendly meat alternatives. Additionally, Multus optimizes a variety of growth factor proteins produced by genetically engineered microorganisms, thereby eliminating the reliance on traditional animal serum-based media. Through its efforts, Multus aims to address the diverse needs of various animal cell types and tissues, facilitating the growth of the cultivated meat sector while significantly reducing the environmental and economic impacts associated with conventional meat production.

Japet Medical Devices is a French biomedical company focused on developing advanced robotic equipment aimed at enhancing the quality of healthcare. The company specializes in wearable robotic exoskeletons that integrate medical and robotic technologies to improve motion and restore balance, thereby facilitating free movement and reducing pain. Their innovative solutions are designed to assist individuals in overcoming mobility challenges, whether related to occupational tasks or daily activities. By prioritizing efficiency and user-friendliness, Japet Medical Devices aims to transform the quality of life for many people through its cutting-edge technologies.

QV Bioelectronics is focused on improving the lives of brain tumor patients through its innovative electric field therapy implant, GRACE. Developed in collaboration with leading neurosurgeons in the UK, GRACE aims to enhance life expectancy for patients suffering from glioblastoma, a brain tumor known for its poor prognosis and limited treatment options. Recognizing the significant gaps in effective therapies, co-founder Dr. Richard Fu, an academic neurosurgeon, teamed up with biomedical engineer Dr. Chris Bullock to address design flaws in existing electric field therapies. Their solution leverages advanced materials science, including the use of graphene, to optimize device performance and patient outcomes. Since its inception, QV Bioelectronics has garnered nearly $1 million in funding from various UK institutions and over $1 million from international life science investors. The company operates from its research hub in Alderley Park, Cheshire, and boasts a multidisciplinary team with extensive experience in bringing innovative medical devices to the clinic.

Intelligent Implants is a bioelectronics company based in Cork, Ireland, founded in 2014 by Erik Zellmer, Rory Murphy, Martin Larsson, and John Zellmer. The company specializes in wireless implantable electronics designed to stimulate, steer, and monitor bone growth. Its innovative electrotherapeutic devices provide solutions to treat diseases and facilitate the recovery of bone and other tissues. By integrating data, engineering, and medical expertise, Intelligent Implants develops active and connected medical devices that enhance patient treatment and support healthcare professionals in decision-making. The company's technology allows for the acceleration and adjustment of bone growth, enabling healthcare providers to utilize electro-therapeutics to manage patient conditions effectively.

Sava is a company focused on revolutionizing health interactions through advanced biosensing technology. Their innovative solutions aim to access bodily information painlessly, in real-time, and at an affordable cost. Sava's technology is particularly beneficial for athletes, as it provides instant feedback about the body's molecular signature, enabling continuous monitoring of glucose and lactate levels. This data helps athletes train more effectively, predict exhaustion, and optimize dietary plans.

Maven is a SaaS pet tech startup that provides a personal vet to track the pet’s safety and health 24/7. It focuses on using technology to improve the quality of life for pets, as well as offering pet owners peace of mind and a way to keep track of their pet's safety, health, and well-being on a continual basis through their own personal veterinarian. It was started by the founders of Findster Technologies in 2021 and is based in the US and Portugal.

Multus is a London-based company established in 2019 that specializes in providing tailored growth media solutions for the cultivated meat industry. By utilizing a machine learning-based approach, Multus develops completely animal-free growth media designed specifically for the efficient growth of animal cells. This innovative technology enables cultivated meat companies to scale their production affordably and sustainably, allowing them to focus on creating delicious and environmentally friendly meat alternatives. Additionally, Multus optimizes a variety of growth factor proteins produced by genetically engineered microorganisms, thereby eliminating the reliance on traditional animal serum-based media. Through its efforts, Multus aims to address the diverse needs of various animal cell types and tissues, facilitating the growth of the cultivated meat sector while significantly reducing the environmental and economic impacts associated with conventional meat production.

Synthace Limited is a London-based company specializing in the development and operation of software solutions for various industries, including health, pharmaceuticals, food, energy, agri-science, industrial biotechnology, and manufacturing. The company offers Antha, a cloud-based platform designed to automate and enhance biological processes. This platform allows life science researchers to digitize experiments from start to finish, enabling them to design, simulate, and execute reproducible experiments with minimal training. Antha facilitates the integration of experimental data and metadata in a streamlined manner, making it easier for scientists to manage their workflows and increasing the scientific value of their research. Synthace's technology empowers researchers to conduct complex experiments without the need for coding, thereby expanding the possibilities of laboratory experimentation. Founded in 2011, Synthace also has a presence in Cambridge, Massachusetts, and maintains a strategic partnership with Microsoft.

Hexafly is a biotech company based in Kells, Ireland, established in 2016. It specializes in the sustainable farming of insects, particularly the Black Soldier Fly larvae, to produce various products for the aquaculture, animal feed, and plant nutrition sectors. The company focuses on converting food waste into protein meals, oils, and fertilizers, promoting a circular economy. Its product range includes insect oil for fish feed, protein additives for aquaculture, Frass for plant nutrition, and Chitin, a versatile bio-polymer utilized in medicine, cosmetics, and food. Hexafly sells its products online, aiming to provide environmentally friendly solutions in agriculture and contribute to a sustainable food system.

DeepSpin GmbH, founded in 2019 and based in Berlin, Germany, specializes in the development of an innovative artificial intelligence-powered magnetic resonance imaging (MRI) system. The company's technology aims to significantly reduce the cost, size, and weight of traditional MRI machines, thereby enhancing accessibility to medical imaging for patients worldwide. By utilizing generative topological design for its hardware and deep learning techniques for image processing, DeepSpin's MRI system seeks to make advanced medical imaging available in a variety of previously underserved healthcare settings. This approach not only aims to improve patient care but also to democratize access to essential medical diagnostics globally.

Nordetect is a Copenhagen-based analytical hardware company established in 2016, specializing in Lab-on-a-chip devices for environmental and agricultural analysis. The company aims to enhance the farming industry by providing medical-grade technology that facilitates reliable nutrient analysis. Nordetect's innovative technology enables farm managers, agricultural service providers, and indoor growers to assess the nitrogen, phosphorus, and potassium content in soil. By delivering clear and actionable data on soil nutrition, the company empowers farmers to make informed decisions about fertilizer use and agricultural practices, ultimately optimizing crop performance and ensuring richer harvests.

ScanTrust SA is a company specializing in a cloud-based IoT platform that enhances supply chain visibility and product authentication. Founded in 2014 and headquartered in Lausanne, Switzerland, with operations in Shanghai, Singapore, and Bangkok, ScanTrust employs secure unique identifiers to connect products and packaging to the Internet. Its offerings include a printer portal for packaging and label partners to integrate secure codes into existing processes, an online portal for real-time business intelligence and supply chain insights, and secure QR codes that can be verified by smartphones. This technology enables brand owners to protect their products from counterfeiting while providing detailed supply chain control and opportunities for consumer engagement.

SunGreenH2 is a company focused on producing high-performance electrolysers for green hydrogen generation using advanced materials and nanotechnology. Founded in 2020 and headquartered in Singapore, with additional offices in Melbourne and London, the company has developed a modular and scalable electrolyser stack that enables on-site hydrogen production at a low cost. By utilizing sunlight and water, SunGreenH2's patented technology facilitates the production of zero-emissions hydrogen, supporting sustainable practices across various industries, including transport, buildings, and specialty chemicals. With over a decade of research in electrochemistry and nanotechnology, SunGreenH2 aims to enable widespread adoption of green hydrogen, contributing to a more sustainable energy landscape.

Nordetect is a Copenhagen-based analytical hardware company established in 2016, specializing in Lab-on-a-chip devices for environmental and agricultural analysis. The company aims to enhance the farming industry by providing medical-grade technology that facilitates reliable nutrient analysis. Nordetect's innovative technology enables farm managers, agricultural service providers, and indoor growers to assess the nitrogen, phosphorus, and potassium content in soil. By delivering clear and actionable data on soil nutrition, the company empowers farmers to make informed decisions about fertilizer use and agricultural practices, ultimately optimizing crop performance and ensuring richer harvests.

Pear Bio is a biotechnology company based in Boston and London that specializes in AI-enabled precision medicine for the treatment of challenging cancers. The company utilizes tumor biopsies and blood samples from cancer patients to identify new therapeutic targets through multi-omics analysis. Pear Bio's proprietary immune-microtumor platform allows for the testing of drug candidates directly on patient tumor samples, enhancing the efficacy of treatments. Additionally, the company employs a unique hydrogel technology that cultivates tumors outside the body, enabling the measurement of drug resistance and streamlining the treatment process. By focusing on tailored drug discovery and smarter combination therapies, Pear Bio aims to improve patient outcomes in cancer care.

TIER Mobility GmbH is a Berlin-based shared micro-mobility provider founded in 2018, specializing in electric kick scooters, e-bikes, and e-mopeds for local commuting. The company aims to transform urban mobility by offering users a convenient way to access light electric vehicles through its application software, which allows them to locate and book available scooters. TIER is dedicated to promoting climate neutrality and reducing urban dependence on cars, contributing to a more sustainable and livable environment. Through its proprietary Energy Network, TIER strives to enhance the efficiency and accessibility of its services, thereby supporting cities in their efforts to improve mobility solutions.

Magellan Life Sciences Ltd. is a synthetic biology company based in London, United Kingdom, established in 2018. The company specializes in developing proprietary protein engineering and expression platforms, focusing on plant-inspired proteins for commercial applications in the food and beverage industries. One of its notable products is brazzein, a protein sweetener designed to provide a non-caloric alternative for consumers, addressing concerns related to sugar content and associated health issues. Additionally, Magellan Life Sciences is advancing its XSeed platform, which further enhances its capabilities in creating novel protein-based molecules tailored for the food, health, and nutrition sectors.

Moirai Biodesign is a biotechnology company focused on developing RNA-based therapies and diagnostics for cancer. Founded in 2016, the company operates from Barcelona, Spain, and specializes in creating non-invasive tests for in-situ diagnosis of various cancers using patient blood samples. Additionally, it provides in-vivo diagnosis systems that assist in surgeries and facilitate patient monitoring. Moirai Biodesign's portfolio includes the discovery of RNA biomarkers, the design of plug-and-play bio devices, and a platform for delivering therapeutic drugs aimed at treating cancer. By advancing these technologies, the company aims to enhance early cancer detection and improve treatment outcomes.

Aō Air specializes in the manufacture and retail of advanced face masks aimed at helping individuals in polluted megacities breathe clean air. The company's innovative masks employ a patented air purifying technology that has been independently validated to be significantly more effective than leading alternatives, filtering out dust, smoke, and other harmful particles. By utilizing an active nanofiltration system, Aō Air's products enable users to commute and exercise in urban environments without the risk of pollution-related health issues. The masks are designed to combine comfort, performance, and style, catering to the needs of urban dwellers seeking to reclaim their right to clean air.

Mobio Interactive Inc. is a Toronto-based company that specializes in developing digital tools aimed at enhancing mental health and well-being for both consumers and clinical populations. Founded in 2014, Mobio has created a range of applications, including Am Mindfulness, Wildflowers Mindfulness, and Actify Mindfulness, which offer medical-grade mindfulness training. These applications utilize an AI-powered digital theragnostic platform that provides clinically validated psychotherapy programs tailored to individual users. They measure the efficacy of mindfulness practices through advanced techniques, including computer vision to assess heart rate, heart rate variability, breathing rate, and blood oxygen levels, without the need for wearable devices. This innovative approach enables users to remotely access personalized mental health support while facilitating the objective quantification of their stress and mood levels over time. Additionally, Mobio has expanded its operations to include offices in Zurich, Switzerland, and Shanghai, China, reflecting its commitment to addressing the growing global demand for effective mental healthcare solutions.

Nordetect is a Copenhagen-based analytical hardware company established in 2016, specializing in Lab-on-a-chip devices for environmental and agricultural analysis. The company aims to enhance the farming industry by providing medical-grade technology that facilitates reliable nutrient analysis. Nordetect's innovative technology enables farm managers, agricultural service providers, and indoor growers to assess the nitrogen, phosphorus, and potassium content in soil. By delivering clear and actionable data on soil nutrition, the company empowers farmers to make informed decisions about fertilizer use and agricultural practices, ultimately optimizing crop performance and ensuring richer harvests.

Babybe GmbH is a medical device company based in Stuttgart, Germany, founded in 2013 by Raphael P. M. Lang and Camilo Anabalon. The company specializes in products designed for premature infants and their mothers, notably the Babybe System, a bionic mattress that enhances the connection between them during incubation. This innovative device replicates the mother's heartbeat, breathing, and voice in real-time, providing multisensory stimulation that supports the infant's neurodevelopment and improves health outcomes. By facilitating a connection when direct contact is not possible, the Babybe System aims to help preterm babies recover more quickly, reduce healthcare costs for families, and enhance patient care within neonatal intensive care units. As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.

GlowDx, established in 2015 and headquartered in Midleton, Ireland, specializes in developing point-of-care diagnostic solutions. The company aims to decentralize molecular testing, enabling local access to improve clinical outcomes and reduce economic burden for patients, particularly in tropical disease diagnosis. GlowDx achieves this by employing novel molecular technology tailored for efficient, on-site diagnostics.

Pear Bio is a biotechnology company based in Boston and London that specializes in AI-enabled precision medicine for the treatment of challenging cancers. The company utilizes tumor biopsies and blood samples from cancer patients to identify new therapeutic targets through multi-omics analysis. Pear Bio's proprietary immune-microtumor platform allows for the testing of drug candidates directly on patient tumor samples, enhancing the efficacy of treatments. Additionally, the company employs a unique hydrogel technology that cultivates tumors outside the body, enabling the measurement of drug resistance and streamlining the treatment process. By focusing on tailored drug discovery and smarter combination therapies, Pear Bio aims to improve patient outcomes in cancer care.

QV Bioelectronics is focused on improving the lives of brain tumor patients through its innovative electric field therapy implant, GRACE. Developed in collaboration with leading neurosurgeons in the UK, GRACE aims to enhance life expectancy for patients suffering from glioblastoma, a brain tumor known for its poor prognosis and limited treatment options. Recognizing the significant gaps in effective therapies, co-founder Dr. Richard Fu, an academic neurosurgeon, teamed up with biomedical engineer Dr. Chris Bullock to address design flaws in existing electric field therapies. Their solution leverages advanced materials science, including the use of graphene, to optimize device performance and patient outcomes. Since its inception, QV Bioelectronics has garnered nearly $1 million in funding from various UK institutions and over $1 million from international life science investors. The company operates from its research hub in Alderley Park, Cheshire, and boasts a multidisciplinary team with extensive experience in bringing innovative medical devices to the clinic.

VoltStorage GmbH is a German company specializing in the development and production of solar energy storage systems. Based in Olching, Germany, it utilizes eco-friendly vanadium redox flow technology to create power storage devices that allow homeowners to store surplus solar energy generated during the day for use at night. This innovative approach aims to provide renewable energy availability around the clock, contributing to a cleaner and fairer world for future generations. VoltStorage also offers installation and technical support services for its products, which are sold online. The company's commitment to sustainability underscores its mission to enhance the accessibility of renewable energy.

Arthronica Ltd is a technology company based in London, United Kingdom, focused on developing an artificial intelligence-based platform for patient monitoring and rehabilitation, specifically targeting chronic rheumatic conditions such as arthritis. Founded in 2018, Arthronica's solutions incorporate advanced features such as skeletal tracking, visual strength assessment, image analysis, and video analysis. The company aims to provide medical practitioners with tools to accurately monitor and predict disease activities, thereby enhancing patient care and treatment outcomes. Currently, Arthronica is engaged in clinical trials in both the United Kingdom and the United States, and it has participated in the Entrepreneur First program, which supports the growth of technology startups.